Clinical Research Directory
Browse clinical research sites, groups, and studies.
QUANTACT : Impact of Pangenomic QUANTitative Alterations in Cancer Therapy
Sponsor: Centre Hospitalier Universitaire de Nice
Summary
"Precision medicine and targeted therapies have played a crucial role over the past ten years in the personalized care of cancer patients. In this retrospective and observational study, we focused on patients for which no standard or curative treatment was available and for which the management was discussed in a Molecular Tumor Board (MTB). The role of the MTB is to decide the most appropriate therapeutic options for patients according to the potential identification of molecular targets. Among the analyses carried out, we focused on a quantitative genome-wide analysis: the CGH/SNP-array (Comparative Genomic Hybridization / Single Nucleotide Polymorphism on array). The objective was to evaluate the impact of CGH/SNP-array analyses in the identification of targeted molecular alterations. "
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
1200
Start Date
2021-02-01
Completion Date
2026-12-31
Last Updated
2025-04-10
Healthy Volunteers
No
Conditions
Locations (1)
CHU de Nice
Nice, France